Brief: Cyclo Therapeutics Announces Publication Of Phase 1 Data For Trappsol Cyclo

Cyclo Therapeutics

18/10/2022 13:06

Oct 18 (Reuters) - Cyclo Therapeutics Inc  CYTH.O :
    * CYCLO THERAPEUTICS ANNOUNCES PUBLICATION OF PHASE 1 DATA
FOR
TRAPPSOL® CYCLO™ FOR THE TREATMENT OF NIEMANN-PICK DISEASE TYPE
C1 (NPC1)
    * CYCLO THERAPEUTICS  - PUBLISHED TRIAL DATA SHOW THAT
TRAPPSOL
CYCLO OVERCOMES NPC1 DEFECT
    * CYCLO THERAPEUTICS  - ADVANCING ONGOING GLOBAL PIVOTAL
PHASE 3
STUDY (TRANSPORTNPC) EVALUATING TRAPPSOL CYCLO FOR NPC1
    * CYCLO THERAPEUTICS  - ADVANCING ONGOING GLOBAL PIVOTAL
PHASE 3
STUDY EVALUATING TRAPPSOL CYCLO FOR NPC1

Source text for Eikon:  ID:nBw2QbQGSa 
Further company coverage:  CYTH.O 
 ((Reuters.Briefs@thomsonreuters.com;))